Moreover, Metarrestin treatment significantly reduces the aggressiveness of blasts educated in a syntenin‐KO host but has no effect on AML blasts grown in wild‐type mice (Appendix Fig S3F). This evidence concerns the gene SDCBP and acute myeloid leukemia.